Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
Ossium Health, Inc.
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Thomas Jefferson University
Thomas Jefferson University
Massachusetts General Hospital
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Thomas Jefferson University
Thomas Jefferson University
Cedars-Sinai Medical Center
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
Northside Hospital, Inc.
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Thomas Jefferson University
H. Lee Moffitt Cancer Center and Research Institute
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
University of Texas Southwestern Medical Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Massachusetts General Hospital
University of Illinois at Chicago
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins